The Journal of Immunology, Vol 156, Issue 4 1594-1600, Copyright © 1996 by American Association of Immunologists

ARTICLES

Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages

CA Pue, RF Mortensen, CB Marsh, HA Pope and MD Wewers
Department of Internal Medicine, Ohio State University, Columbus 43210, USA.

C-reactive protein (CRP), the major acute phase protein in humans, was purified free of endotoxin (LPS) (< 10 pg of LPS/mg of purified CRP) and evaluated for its ability to modulate LPS-induced production of IL- 1 beta and IL-1 receptor antagonist (IL-1ra) from human PBMC and lung macrophages. PBMC (5 x 10(6)/ml) released low levels of IL-1 beta in response to either CRP (250 micrograms/ml) or LPS (100 ng/ml) for 18 h (0.3 +/- 0.1 and 1.5 +/- 0.7 ng/ml, respectively). However, when CRP (250 micrograms/ml) and LPS (100 ng/ml) were combined, PBMC released 9.7 +/- 2.9 ng/ml (p < 0.001 vs LPS alone). This synergy was removed by immunodepletion of CRP before stimulation. With respect to IL-1ra, although CRP induced IL-1ra production from PBMC (0.8 +/- 0.3 ng/ml control, 2.6 +/- 1.3 ng/ml with CRP), CRP did not synergize with LPS for IL-1ra production (15.0 +/- 0.7 ng/ml LPS alone vs 15.4 +/- 1.4 ng/ml LPS and CRP). In contrast, lung macrophages responded to CRP quite differently than PBMC. Macrophages (10(6)/ml) were not stimulated to produce IL-1 beta or IL-1ra by CRP alone. When combined with LPS, CRP inhibited IL-1 beta and IL-1ra release induced by LPS (for IL-1 beta release, LPS induced 3.0 +/- 1.7 ng/ml vs 1.1 +/- 0.4 for combined LPS and CRP; for IL-1ra release, LPS induced 12.9 +/- 2.3 ng/ml vs 7.6 +/- 2.3 ng/ml for combined LPS and CRP). These data suggest that acute phase levels of CRP may have divergent effects depending on the target population. CRP may be largely proinflammatory to blood monocytes responding to LPS since IL-1 beta production is augmented over IL-1ra production. However, in tissue compartments the effects of CRP may be largely immunosuppressive to LPS-induced tissue macrophage IL-1 beta production.

This article has been cited by other articles:

				B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF]

				F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F. Mach C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes J. Leukoc. Biol., October 1, 2008; 84(4): 1109 - 1119. [Abstract] [Full Text] [PDF]

				G. Liuzzo, M. Santamaria, L. M. Biasucci, M. Narducci, V. Colafrancesco, A. Porto, S. Brugaletta, M. Pinnelli, V. Rizzello, A. Maseri, et al. Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein: Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide-Free C-Reactive Protein on Human Monocytes Via Nuclear Factor Kappa-B Activation J. Am. Coll. Cardiol., January 16, 2007; 49(2): 185 - 194. [Abstract] [Full Text] [PDF]

				C. Mold and T. W. Du Clos C-Reactive Protein Increases Cytokine Responses to Streptococcus pneumoniae through Interactions with Fc{gamma} Receptors. J. Immunol., June 15, 2006; 176(12): 7598 - 7604. [Abstract] [Full Text] [PDF]

				A. M. W. Petersen and B. K. Pedersen The anti-inflammatory effect of exercise J Appl Physiol, April 1, 2005; 98(4): 1154 - 1162. [Abstract] [Full Text] [PDF]

				S. M. A. Lobo, F. R. M. Lobo, D. P. Bota, F. Lopes-Ferreira, H. M. Soliman, C. Melot, and J.-L. Vincent C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patients Chest, June 1, 2003; 123(6): 2043 - 2049. [Abstract] [Full Text] [PDF]

				C. Casals, J. Arias-Diaz, F. Valino, A. Saenz, C. Garcia, J. L. Balibrea, and E. Vara Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L466 - L472. [Abstract] [Full Text] [PDF]

				C. Mold, W. Rodriguez, B. Rodic-Polic, and T. W. Du Clos C-Reactive Protein Mediates Protection from Lipopolysaccharide Through Interactions With Fc{gamma}R J. Immunol., December 15, 2002; 169(12): 7019 - 7025. [Abstract] [Full Text] [PDF]

				A. Steensberg, C. Keller, R. L. Starkie, T. Osada, M. A. Febbraio, and B. K. Pedersen IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1272 - E1278. [Abstract] [Full Text] [PDF]

				M. A. FEBBRAIO and B. K. PEDERSEN Muscle-derived interleukin-6: mechanisms for activation and possible biological roles FASEB J, September 1, 2002; 16(11): 1335 - 1347. [Abstract] [Full Text] [PDF]

				G. Liuzzo, D. J. Angiolillo, A. Buffon, V. Rizzello, C. Colizzi, F. Ginnetti, L. M. Biasucci, and A. Maseri Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable Angina Circulation, May 8, 2001; 103(18): 2236 - 2241. [Abstract] [Full Text] [PDF]

				A. Nakagomi, S. B. Freedman, and C. L. Geczy Interferon-{gamma} and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by C-Reactive Protein : Relationship With Age, Sex, and Hormone Replacement Treatment Circulation, April 18, 2000; 101(15): 1785 - 1791. [Abstract] [Full Text] [PDF]

				G. Liuzzo, L. M. Biasucci, J. R. Gallimore, G. Caligiuri, A. Buffon, A. G. Rebuzzi, M. B. Pepys, and A. Maseri Enhanced inflammatory response in patients with preinfarction unstable angina J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1696 - 1703. [Abstract] [Full Text] [PDF]

				J. L. Anderson, J. B. Muhlestein, J. Carlquist, A. Allen, S. Trehan, C. Nielson, S. Hall, J. Brady, M. Egger, B. Horne, et al. Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for Chlamydia pneumoniae Infection : The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study Circulation, March 30, 1999; 99(12): 1540 - 1547. [Abstract] [Full Text] [PDF]

				G. Liuzzo, A. Buffon, L. M. Biasucci, J. R. Gallimore, G. Caligiuri, A. Vitelli, S. Altamura, G. Ciliberto, A. G. Rebuzzi, F. Crea, et al. Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina Circulation, December 1, 1998; 98(22): 2370 - 2376. [Abstract] [Full Text] [PDF]

				T. Endo, F. Ogushi, T. Kawano, and S. Sone Comparison of the Regulations by Th2-type Cytokines of the Arachidonic-Acid Metabolic Pathway in Human Alveolar Macrophages and Monocytes Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 300 - 307. [Abstract] [Full Text]

				O. MICHEL, A.-M. NAGY, M. SCHROEVEN, J. DUCHATEAU, J. NEVE, P. FONDU, and R. SERGYSELS Dose-Response Relationship to Inhaled Endotoxin in Normal Subjects Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1157 - 1164. [Abstract] [Full Text] [PDF]

				C. CASALS, A. VARELA, M. L. F. RUANO, F. VALIÑO, J. PÉREZ-GIL, N. TORRE, E. JORGE, F. TENDILLO, and J. L. CASTILLO-OLIVARES Increase of C-Reactive Protein and Decrease of Surfactant Protein A in Surfactant after Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 43 - 49. [Abstract] [Full Text]